MOVING AHEAD REQUIRES A SURE PATH FORWARD
Trials are inherently risky, and every detail matters. We spot risks before they become problems to help you avoid costly delays through an array of solutions that provide confidence at every turn.
ENHANCE TRIAL OVERSIGHT
Run more efficient trials by unlocking hidden insights
enable site optimization
Generate high-quality data by optimizing site selection and performance
increase patient engagement
Equip patients with the tools to take control of their health
ensure safety and measure efficacy
By driving high-quality data
THE ERT EXPERT PLATFORM
The ERT EXPERT® platform is the underlying proprietary technology that powers all ERT solutions. Improve trial visibility and performance and reduce time-to-market with confidence, agility and acceleration.
MINIMIZe RISK AND UNCERTAINTY
We enable the flexibility and adaptability you need to accelerate through hurdles for faster speed to market. Here’s how:
Every trial runs into unexpected challenges. With more than 10,000 trials under our belt, we’ve seen most of them before and have the expertise to put your trial back on course.
We’ll protect the success of your trial before there’s ever an issue, with near real-time access to study, program and enterprise-level performance.
NEWS & EVENTS
March 1, 2018
ERT Recognized for Advanced Central Trial Analytics and Patient Engagement
Centralized Clinical Trial Analytics and Voice Assistance Data Capture solutions improve patient engagement and accelerate clinical development.
March 7, 2018
Clinical Trial Data Demands Spur Changes: Impact of Rising Complexity on Data Management
This article, featuring commentary from ERT’s Brion Regan, addresses the database lock challenges trial sponsors are wrestling with and explores some strategic – yet practical – changes that can address this issue.
March 19, 2018
ERT Recognized for Supporting Heart Health in Children
ERT and its Chief Medical Officer, Robert Kleiman, MD, are being honored for their contributions to the success of Simon’s Fund. Since 2014, every heart screening that Simon’s Fund provides has been equipped with ECG machines donated by ERT. Dr. Kleiman was instrumental in the development of Simon’s Fund’s digital platform, HeartBytes, a first-of-its-kind registry that gathers and disseminates heart screening information to qualified researchers free of charge, for the purpose of advancing life-saving research across the United States.